Endopeptidase.

Endopeptidases cut proteins at internal bonds, leaving shorter peptides that still need trimming from the ends. Exopeptidases such as carboxypeptidase and aminopeptidase do that trimming and release free amino acids. Blended digestive enzyme products combine both classes because neither finishes protein breakdown alone. This is formulation convention rather than a clinical finding.

Pepsin works in the stomach at low pH and breaks large proteins into large peptide fragments. Pancreatic endopeptidases like trypsin and chymotrypsin then act on those fragments at intestinal pH. The two operate in different compartments, so the earlier step widens the substrate pool for the later one. Products combining them mirror the physiological sequence.

Acid-active endopeptidases need a low gastric pH to reach their working range. Betaine HCl is used in supplements to lower stomach pH transiently. Where gastric acid output is low the enzyme has less activity regardless of dose. This is a pH-availability argument, not a demonstrated clinical outcome.

Pancreatin supplies trypsin and chymotrypsin, both endopeptidases, plus lipase and amylase. Adding a separate microbial endopeptidase raises total proteolytic activity across a wider pH range than pancreatin covers alone. Buyers should count total protease activity rather than assume the two are independent additions. Overlap is the point to watch here.

Bromelain from pineapple cleaves internal peptide bonds and is active across a broad pH range. Pairing it with bacterial or fungal endopeptidases broadens the pH window over which proteolysis continues through the gut. The effect is additive activity on the same class of bond, not a novel mechanism. Activity units matter more than milligrams when comparing.

Endopeptidases act on dietary protein, so a high-protein load is the substrate rather than a partner in the usual sense. Protein powders sometimes carry added protease to speed hydrolysis of the intact protein. Whether this changes how much amino acid reaches circulation in a healthy person is not settled. Read it as mechanistic rather than clinical.

Gut bacteria carry DL-endopeptidases that remodel peptidoglycan, and the abundance of those bacterial enzymes tracks with microbiota maturation. A 2026 report linked low DL-endopeptidase carriage after antibiotics to an immature infant gut community. That is a microbial ecology observation, not evidence that a supplemental enzyme does the same thing. The two uses of the word endopeptidase are easy to conflate and should not be.

A large family of endopeptidases, the metalloendopeptidases, hold a zinc ion at the catalytic site and cannot cleave without it. This is settled enzymology and applies to endogenous enzymes such as neprilysin and the matrix metalloproteinases. It does not follow that oral zinc raises digestive proteolysis in a person with normal zinc status. The cofactor requirement is structural, not a dosing recommendation.

Serine endopeptidases of the trypsin family bind calcium at a structural site that slows self-digestion and keeps the fold intact. Enzyme preparations are often formulated with calcium salts for this reason. The relevance is to shelf and lumen stability of the preparation rather than to the person's calcium intake. This is formulation practice.